Literature DB >> 24095042

Vein graft failure.

Christopher D Owens1, Warren J Gasper2, Amreen S Rahman2, Michael S Conte2.   

Abstract

After the creation of an autogenous lower extremity bypass graft, the vein must undergo a series of dynamic structural changes to stabilize the arterial hemodynamic forces. These changes, which are commonly referred to as remodeling, include an inflammatory response, the development of a neointima, matrix turnover, and cellular proliferation and apoptosis. The sum total of these processes results in dramatic alterations in the physical and biomechanical attributes of the arterialized vein. The most clinically obvious and easily measured of these is lumen remodeling of the graft. However, although somewhat less precise, wall thickness, matrix composition, and endothelial changes can be measured in vivo within the healing vein graft. Recent translational work has demonstrated the clinical relevance of remodeling as it relates to vein graft patency and the systemic factors influencing it. By correlating histologic and molecular changes in the vein, insights into potential therapeutic strategies to prevent bypass failure and areas for future investigation are explored.
Copyright © 2015 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24095042      PMCID: PMC4391818          DOI: 10.1016/j.jvs.2013.08.019

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  183 in total

Review 1.  Stranger in a strange land: the pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteries.

Authors:  J L Cox; D A Chiasson; A I Gotlieb
Journal:  Prog Cardiovasc Dis       Date:  1991 Jul-Aug       Impact factor: 8.194

Review 2.  Resolution of inflammation: the beginning programs the end.

Authors:  Charles N Serhan; John Savill
Journal:  Nat Immunol       Date:  2005-12       Impact factor: 25.606

3.  Cyclic strain-induced monocyte chemotactic protein-1 gene expression in endothelial cells involves reactive oxygen species activation of activator protein 1.

Authors:  B S Wung; J J Cheng; H J Hsieh; Y J Shyy; D L Wang
Journal:  Circ Res       Date:  1997-07       Impact factor: 17.367

4.  Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease.

Authors:  Kim Midwood; Sandra Sacre; Anna M Piccinini; Julia Inglis; Annette Trebaul; Emma Chan; Stefan Drexler; Nidhi Sofat; Masahide Kashiwagi; Gertraud Orend; Fionula Brennan; Brian Foxwell
Journal:  Nat Med       Date:  2009-06-28       Impact factor: 53.440

5.  Targeting C-reactive protein for the treatment of cardiovascular disease.

Authors:  Mark B Pepys; Gideon M Hirschfield; Glenys A Tennent; J Ruth Gallimore; Melvyn C Kahan; Vittorio Bellotti; Philip N Hawkins; Rebecca M Myers; Martin D Smith; Alessandra Polara; Alexander J A Cobb; Steven V Ley; J Andrew Aquilina; Carol V Robinson; Isam Sharif; Gillian A Gray; Caroline A Sabin; Michelle C Jenvey; Simon E Kolstoe; Darren Thompson; Stephen P Wood
Journal:  Nature       Date:  2006-04-27       Impact factor: 49.962

6.  Histologic fate of the venous coronary artery bypass in dogs.

Authors:  W R Brody; W W Angeli; J C Kosek
Journal:  Am J Pathol       Date:  1972-01       Impact factor: 4.307

7.  The structural study of the saphenous vein.

Authors:  C Cheanvechai; D B Effler; J R Hooper; E M Eschenbruch; W C Sheldon; F M Sones; H S Levin; W A Hawk
Journal:  Ann Thorac Surg       Date:  1975-12       Impact factor: 4.330

8.  Abnormal monocyte recruitment and collateral artery formation in monocyte chemoattractant protein-1 deficient mice.

Authors:  Michiel Voskuil; Imo E Hoefer; Niels van Royen; Jing Hua; Stijn de Graaf; Christoph Bode; Ivo R Buschmann; Jan J Piek
Journal:  Vasc Med       Date:  2004-11       Impact factor: 3.239

9.  Degradation of sulfated proteoglycans in the subendothelial extracellular matrix by human platelet heparitinase.

Authors:  J Yahalom; A Eldor; Z Fuks; I Vlodavsky
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

Review 10.  Pattern recognition by pentraxins.

Authors:  Alok Agrawal; Prem Prakash Singh; Barbara Bottazzi; Cecilia Garlanda; Alberto Mantovani
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

View more
  39 in total

Review 1.  Vascular Smooth Muscle as a Target for Novel Therapeutics.

Authors:  Karen E Porter; Kirsten Riches
Journal:  Curr Diab Rep       Date:  2015-10       Impact factor: 4.810

2.  Scavenger receptor class A member 5 (SCARA5) and suprabasin (SBSN) are hub genes of coexpression network modules associated with peripheral vein graft patency.

Authors:  Richard D Kenagy; Mete Civelek; Shinsuke Kikuchi; Lihua Chen; Anthony Grieff; Michael Sobel; Aldons J Lusis; Alexander W Clowes
Journal:  J Vasc Surg       Date:  2015-04-30       Impact factor: 4.268

3.  Mature Vascular Smooth Muscle Cells, but Not Endothelial Cells, Serve as the Major Cellular Source of Intimal Hyperplasia in Vein Grafts.

Authors:  Weiwei Wu; Chunyan Wang; Huimei Zang; Lei Qi; Mohamad Azhar; Mitzi Nagarkatti; Prakash Nagarkatti; Guoshuai Cai; Mary C M Weiser-Evans; Taixing Cui
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-06-04       Impact factor: 8.311

4.  A Multiscale Computational Framework to Understand Vascular Adaptation.

Authors:  Marc Garbey; Mahbubur Rahman; Scott A Berceli
Journal:  J Comput Sci       Date:  2015-05-01

Review 5.  Historical Perspective and Future Direction of Blood Vessel Developments.

Authors:  Sashka Dimitrievska; Laura E Niklason
Journal:  Cold Spring Harb Perspect Med       Date:  2018-02-01       Impact factor: 6.915

6.  Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rabbit vein graft model.

Authors:  Bian Wu; Evan C Werlin; Mian Chen; Giorgio Mottola; Anuran Chatterjee; Kevin D Lance; Daniel A Bernards; Brian E Sansbury; Matthew Spite; Tejal A Desai; Michael S Conte
Journal:  J Vasc Surg       Date:  2018-07-29       Impact factor: 4.268

Review 7.  Can Specialized Pro-resolving Mediators Deliver Benefit Originally Expected from Fish Oil?

Authors:  Martin D Rosenthal; Jayshil Patel; Kyle Staton; Robert G Martindale; Frederick A Moore; Gilbert R Upchurch
Journal:  Curr Gastroenterol Rep       Date:  2018-08-04

8.  Hemodynamic Influence on Smooth Muscle Cell Kinetics and Phenotype During Early Vein Graft Adaptation.

Authors:  Benjamin Klein; Anthony Destephens; Leanne Dumeny; Qiongyao Hu; Yong He; Kerri O'Malley; Zhihua Jiang; Roger Tran-Son-Tay; Scott Berceli
Journal:  Ann Biomed Eng       Date:  2016-09-13       Impact factor: 3.934

Review 9.  Biomaterial-Based Approaches to Address Vein Graft and Hemodialysis Access Failures.

Authors:  Timothy C Boire; Daniel A Balikov; Yunki Lee; Christy M Guth; Joyce Cheung-Flynn; Hak-Joon Sung
Journal:  Macromol Rapid Commun       Date:  2016-09-27       Impact factor: 5.734

Review 10.  Membrane-mediated regulation of vascular identity.

Authors:  Takuya Hashimoto; Masayuki Tsuneki; Trenton R Foster; Jeans M Santana; Hualong Bai; Mo Wang; Haidi Hu; Jesse J Hanisch; Alan Dardik
Journal:  Birth Defects Res C Embryo Today       Date:  2016-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.